Incidence of the Factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-Syndrome

Thrombosis Research

Volumn 100, Issue 4, 2000, Pages 363-365

  Von Tempelhoff, Georg Friedrich ^a   Heilmann, Lothar ^a   Spanuth, Eberhard ^a   Kunzmann, Erich ^a   Hommel, Gerhard ^b  

^a Gesundheits und Pflegezentrum Russelsheim   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antiphospholipid syndrome; Factor V Leiden; HELLP, Hemolysis, elevated liver enzymes, low platelets; HELLP Syndrome; Preeclampsia; Prothrombin mutation; Thrombophila

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING INHIBITOR; PHOSPHOLIPID ANTIBODY;

CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; LETTER; MAJOR CLINICAL STUDY; MUTATION; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; RISK; THROMBOPHILIA;

ANTIBODIES, ANTIPHOSPHOLIPID; BLOOD COAGULATION DISORDERS; ECLAMPSIA; FACTOR V; FEMALE; HELLP SYNDROME; HUMANS; INCIDENCE; POINT MUTATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOPHILIA;

EID: 0034668897     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00312-1     Document Type: Letter

References (5)

1. Increased frequency of genetic thrombophilia in women with complications of pregnancy
2. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy
3. Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria
4. Activated Protein C Resistance (FV;Q506) and pregnancy
5. Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome